Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Non-Small-Cell Lung | 45 | 2024 | 5248 | 2.750 |
Why?
|
Lung Neoplasms | 69 | 2024 | 13249 | 2.690 |
Why?
|
Quinazolines | 27 | 2019 | 1363 | 2.170 |
Why?
|
Protein Kinase Inhibitors | 41 | 2024 | 5640 | 1.940 |
Why?
|
CCAAT-Enhancer-Binding Protein-alpha | 7 | 2019 | 130 | 1.740 |
Why?
|
Drug Resistance, Neoplasm | 23 | 2024 | 5230 | 1.400 |
Why?
|
Quinazolinones | 4 | 2021 | 223 | 1.320 |
Why?
|
Mutation | 50 | 2024 | 29950 | 1.230 |
Why?
|
Antineoplastic Agents | 30 | 2024 | 13629 | 1.090 |
Why?
|
Apoptosis | 21 | 2024 | 9497 | 1.050 |
Why?
|
Receptor Protein-Tyrosine Kinases | 15 | 2024 | 1614 | 1.000 |
Why?
|
Pyrazoles | 11 | 2024 | 1992 | 0.990 |
Why?
|
Leukemia, Myeloid, Acute | 7 | 2021 | 3606 | 0.920 |
Why?
|
Lactams | 2 | 2024 | 154 | 0.920 |
Why?
|
Single-Cell Analysis | 2 | 2024 | 2368 | 0.780 |
Why?
|
Aminopyridines | 2 | 2024 | 564 | 0.740 |
Why?
|
Mutagenesis, Insertional | 5 | 2021 | 652 | 0.740 |
Why?
|
Molecular Targeted Therapy | 7 | 2024 | 2805 | 0.730 |
Why?
|
Cell Line, Tumor | 39 | 2024 | 16905 | 0.720 |
Why?
|
Exons | 11 | 2023 | 2391 | 0.710 |
Why?
|
Benzene Derivatives | 1 | 2019 | 53 | 0.680 |
Why?
|
Adenocarcinoma | 17 | 2020 | 6310 | 0.680 |
Why?
|
Alternative Splicing | 3 | 2020 | 1091 | 0.660 |
Why?
|
Styrenes | 1 | 2018 | 23 | 0.640 |
Why?
|
Genes, erbB-1 | 4 | 2019 | 160 | 0.640 |
Why?
|
Alkynes | 1 | 2019 | 313 | 0.620 |
Why?
|
Cytidine Deaminase | 1 | 2020 | 245 | 0.620 |
Why?
|
Janus Kinase 2 | 4 | 2022 | 541 | 0.580 |
Why?
|
Proto-Oncogene Proteins | 10 | 2017 | 4494 | 0.520 |
Why?
|
CCAAT-Binding Factor | 1 | 2015 | 21 | 0.500 |
Why?
|
HL-60 Cells | 5 | 2024 | 363 | 0.500 |
Why?
|
Drug Screening Assays, Antitumor | 7 | 2024 | 717 | 0.480 |
Why?
|
Pyridines | 8 | 2017 | 2877 | 0.450 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2010 | 1135 | 0.440 |
Why?
|
Oncogene Proteins, Fusion | 7 | 2024 | 1591 | 0.400 |
Why?
|
Cell Differentiation | 7 | 2021 | 11480 | 0.370 |
Why?
|
Receptor, erbB-2 | 3 | 2022 | 2544 | 0.370 |
Why?
|
Chromans | 1 | 2010 | 117 | 0.350 |
Why?
|
Benzopyrans | 1 | 2010 | 63 | 0.350 |
Why?
|
Transcription Factors | 5 | 2023 | 12100 | 0.350 |
Why?
|
Myeloproliferative Disorders | 3 | 2022 | 612 | 0.350 |
Why?
|
Nitrophenols | 1 | 2010 | 169 | 0.340 |
Why?
|
Protein-Arginine N-Methyltransferases | 1 | 2010 | 131 | 0.330 |
Why?
|
Sesquiterpenes | 1 | 2010 | 176 | 0.330 |
Why?
|
beta Catenin | 1 | 2014 | 1043 | 0.330 |
Why?
|
Structure-Activity Relationship | 7 | 2024 | 3086 | 0.320 |
Why?
|
Transcriptional Activation | 5 | 2021 | 1755 | 0.320 |
Why?
|
Erythroid Cells | 1 | 2010 | 235 | 0.310 |
Why?
|
Biomimetic Materials | 1 | 2010 | 173 | 0.310 |
Why?
|
Sequence Deletion | 2 | 2013 | 1493 | 0.300 |
Why?
|
Small Cell Lung Carcinoma | 2 | 2024 | 421 | 0.300 |
Why?
|
Xenograft Model Antitumor Assays | 8 | 2022 | 3584 | 0.280 |
Why?
|
Sulfonamides | 2 | 2022 | 1973 | 0.280 |
Why?
|
Humans | 97 | 2024 | 760261 | 0.270 |
Why?
|
Molecular Structure | 5 | 2024 | 1895 | 0.270 |
Why?
|
DNA | 1 | 2020 | 7236 | 0.270 |
Why?
|
Lung | 5 | 2024 | 9989 | 0.260 |
Why?
|
Mice | 29 | 2024 | 81216 | 0.260 |
Why?
|
Taxoids | 1 | 2009 | 668 | 0.250 |
Why?
|
bcl-X Protein | 2 | 2024 | 413 | 0.250 |
Why?
|
Animals | 36 | 2024 | 167940 | 0.240 |
Why?
|
Biphenyl Compounds | 1 | 2010 | 988 | 0.240 |
Why?
|
Gene Expression Profiling | 4 | 2024 | 9388 | 0.240 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2022 | 1408 | 0.240 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2020 | 896 | 0.240 |
Why?
|
Cyclins | 1 | 2006 | 593 | 0.240 |
Why?
|
Protein-Tyrosine Kinases | 7 | 2019 | 2415 | 0.230 |
Why?
|
Acrylamides | 3 | 2019 | 260 | 0.220 |
Why?
|
Pyrogallol | 1 | 2022 | 8 | 0.220 |
Why?
|
Leukemia, Neutrophilic, Chronic | 1 | 2002 | 13 | 0.210 |
Why?
|
Computer Simulation | 1 | 2016 | 6210 | 0.210 |
Why?
|
Drug Tolerance | 1 | 2024 | 369 | 0.210 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2023 | 2823 | 0.210 |
Why?
|
Gene Expression Regulation, Neoplastic | 7 | 2024 | 8498 | 0.210 |
Why?
|
Up-Regulation | 6 | 2021 | 4127 | 0.210 |
Why?
|
Lactams, Macrocyclic | 1 | 2024 | 315 | 0.200 |
Why?
|
Granulocytes | 2 | 2018 | 551 | 0.200 |
Why?
|
Calpain | 1 | 2002 | 145 | 0.200 |
Why?
|
Fibroblast Growth Factor 9 | 1 | 2021 | 13 | 0.200 |
Why?
|
Membrane Proteins | 2 | 2010 | 7854 | 0.200 |
Why?
|
Cell Proliferation | 9 | 2023 | 10434 | 0.190 |
Why?
|
HSP90 Heat-Shock Proteins | 2 | 2018 | 423 | 0.190 |
Why?
|
Epithelial-Mesenchymal Transition | 3 | 2023 | 730 | 0.190 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 3 | 2021 | 286 | 0.190 |
Why?
|
Peroxiredoxins | 1 | 2021 | 51 | 0.190 |
Why?
|
Histone Acetyltransferases | 1 | 2023 | 337 | 0.190 |
Why?
|
Mice, Transgenic | 5 | 2024 | 9531 | 0.180 |
Why?
|
Interleukin-6 | 2 | 2024 | 3207 | 0.180 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 2021 | 317 | 0.180 |
Why?
|
Models, Biological | 2 | 2016 | 9468 | 0.180 |
Why?
|
Peptide Library | 2 | 2012 | 347 | 0.180 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2024 | 10829 | 0.180 |
Why?
|
Proto-Oncogene Proteins c-akt | 4 | 2022 | 2449 | 0.180 |
Why?
|
STAT3 Transcription Factor | 1 | 2024 | 877 | 0.170 |
Why?
|
Indolizines | 1 | 2019 | 30 | 0.170 |
Why?
|
Aniline Compounds | 3 | 2019 | 1068 | 0.170 |
Why?
|
Gene Rearrangement | 4 | 2020 | 1122 | 0.170 |
Why?
|
Blotting, Western | 6 | 2015 | 5039 | 0.170 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2021 | 352 | 0.160 |
Why?
|
Gene Deletion | 1 | 2007 | 2668 | 0.160 |
Why?
|
Genes, Neoplasm | 1 | 2020 | 370 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-met | 4 | 2015 | 567 | 0.150 |
Why?
|
Signal Transduction | 6 | 2023 | 23363 | 0.150 |
Why?
|
Cytoskeletal Proteins | 1 | 2024 | 1344 | 0.150 |
Why?
|
Gene Knockout Techniques | 1 | 2021 | 803 | 0.150 |
Why?
|
Epithelial Cells | 1 | 2010 | 3665 | 0.150 |
Why?
|
Leukopoiesis | 1 | 2018 | 55 | 0.150 |
Why?
|
Enzyme Inhibitors | 3 | 2021 | 3726 | 0.150 |
Why?
|
Gene Expression Regulation, Leukemic | 3 | 2021 | 645 | 0.150 |
Why?
|
Myeloid Cells | 3 | 2021 | 821 | 0.150 |
Why?
|
NAD | 1 | 2021 | 610 | 0.150 |
Why?
|
Base Sequence | 5 | 2017 | 12447 | 0.140 |
Why?
|
Organophosphorus Compounds | 1 | 2018 | 202 | 0.140 |
Why?
|
Salicylamides | 1 | 2016 | 33 | 0.140 |
Why?
|
Trans-Activators | 3 | 2017 | 2861 | 0.140 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2021 | 1446 | 0.140 |
Why?
|
Embolism, Air | 1 | 2017 | 110 | 0.140 |
Why?
|
Carbazoles | 1 | 2018 | 221 | 0.140 |
Why?
|
4-Butyrolactone | 1 | 2016 | 62 | 0.140 |
Why?
|
Microtubule-Associated Proteins | 1 | 2021 | 1078 | 0.130 |
Why?
|
Piperidines | 3 | 2018 | 1650 | 0.130 |
Why?
|
Liver Neoplasms | 1 | 2012 | 4317 | 0.130 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2024 | 4024 | 0.130 |
Why?
|
Phosphorylation | 9 | 2020 | 8314 | 0.130 |
Why?
|
Gene Amplification | 3 | 2015 | 1085 | 0.130 |
Why?
|
Tumor Burden | 3 | 2021 | 1897 | 0.120 |
Why?
|
Mixed Function Oxygenases | 1 | 2016 | 265 | 0.120 |
Why?
|
Brain Neoplasms | 3 | 2022 | 8984 | 0.120 |
Why?
|
RNA Splicing | 1 | 2020 | 914 | 0.120 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2016 | 345 | 0.110 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2016 | 453 | 0.110 |
Why?
|
Fatal Outcome | 3 | 2017 | 1833 | 0.110 |
Why?
|
Tumor Necrosis Factor-alpha | 4 | 2016 | 4357 | 0.110 |
Why?
|
Genes, Reporter | 2 | 2015 | 1531 | 0.110 |
Why?
|
Drug Design | 2 | 2016 | 1062 | 0.110 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2020 | 2866 | 0.110 |
Why?
|
Autopsy | 1 | 2017 | 1007 | 0.110 |
Why?
|
Killer Cells, Natural | 1 | 2022 | 2204 | 0.110 |
Why?
|
Luciferases | 1 | 2015 | 716 | 0.110 |
Why?
|
Transcription, Genetic | 5 | 2021 | 7593 | 0.110 |
Why?
|
Drug Synergism | 2 | 2016 | 1755 | 0.110 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2020 | 2058 | 0.110 |
Why?
|
Cell Survival | 3 | 2021 | 5796 | 0.110 |
Why?
|
Cell Line | 5 | 2021 | 15626 | 0.110 |
Why?
|
Small Molecule Libraries | 1 | 2018 | 734 | 0.100 |
Why?
|
Disease Models, Animal | 6 | 2021 | 18134 | 0.100 |
Why?
|
Doxycycline | 1 | 2014 | 337 | 0.100 |
Why?
|
Protein Stability | 1 | 2014 | 566 | 0.100 |
Why?
|
ATP Citrate (pro-S)-Lyase | 1 | 2012 | 22 | 0.100 |
Why?
|
Tretinoin | 1 | 2015 | 519 | 0.100 |
Why?
|
Neutrophils | 2 | 2002 | 3770 | 0.100 |
Why?
|
Hepatocyte Nuclear Factor 3-beta | 1 | 2012 | 64 | 0.100 |
Why?
|
Promoter Regions, Genetic | 3 | 2021 | 5784 | 0.100 |
Why?
|
Hematopoiesis | 2 | 2018 | 2063 | 0.100 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2019 | 11708 | 0.100 |
Why?
|
Mutation, Missense | 2 | 2014 | 2563 | 0.100 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2018 | 1346 | 0.100 |
Why?
|
DNA Methylation | 3 | 2021 | 4374 | 0.090 |
Why?
|
K562 Cells | 2 | 2010 | 640 | 0.090 |
Why?
|
PTEN Phosphohydrolase | 1 | 2017 | 1115 | 0.090 |
Why?
|
Phosphatidic Acids | 1 | 2010 | 49 | 0.090 |
Why?
|
Tumor Microenvironment | 3 | 2022 | 3826 | 0.090 |
Why?
|
E2F Transcription Factors | 1 | 2011 | 269 | 0.090 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2017 | 2927 | 0.090 |
Why?
|
Fluorescent Antibody Technique | 1 | 2015 | 2473 | 0.090 |
Why?
|
Tumor Cells, Cultured | 2 | 2016 | 6131 | 0.090 |
Why?
|
Anti-Retroviral Agents | 1 | 2020 | 1780 | 0.090 |
Why?
|
Dual Specificity Phosphatase 6 | 1 | 2010 | 12 | 0.090 |
Why?
|
MAP Kinase Signaling System | 3 | 2016 | 1483 | 0.090 |
Why?
|
Pyrimidines | 2 | 2021 | 3011 | 0.090 |
Why?
|
Cell Growth Processes | 2 | 2013 | 384 | 0.090 |
Why?
|
Purines | 2 | 2024 | 601 | 0.090 |
Why?
|
Proto-Oncogene Protein c-ets-1 | 1 | 2010 | 63 | 0.090 |
Why?
|
Etoposide | 1 | 2011 | 630 | 0.080 |
Why?
|
Alkanesulfonic Acids | 1 | 2012 | 199 | 0.080 |
Why?
|
Glioblastoma | 2 | 2022 | 3482 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3613 | 0.080 |
Why?
|
High-Throughput Screening Assays | 1 | 2015 | 943 | 0.080 |
Why?
|
Immunohistochemistry | 4 | 2018 | 11064 | 0.080 |
Why?
|
Head and Neck Neoplasms | 1 | 2023 | 2880 | 0.080 |
Why?
|
Neoplasm Staging | 4 | 2021 | 11141 | 0.080 |
Why?
|
Mutant Proteins | 2 | 2010 | 492 | 0.080 |
Why?
|
Female | 27 | 2021 | 391011 | 0.080 |
Why?
|
Cells, Cultured | 3 | 2020 | 18968 | 0.080 |
Why?
|
Polycythemia Vera | 1 | 2010 | 159 | 0.080 |
Why?
|
Carrier Proteins | 2 | 2012 | 4938 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3618 | 0.080 |
Why?
|
Mitochondria | 2 | 2021 | 3598 | 0.080 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2010 | 3764 | 0.080 |
Why?
|
NF-kappa B | 1 | 2016 | 2486 | 0.080 |
Why?
|
Glucose Transporter Type 4 | 1 | 2008 | 240 | 0.070 |
Why?
|
Thoracic Wall | 1 | 2009 | 199 | 0.070 |
Why?
|
Mice, Nude | 3 | 2021 | 3605 | 0.070 |
Why?
|
Oleanolic Acid | 1 | 2007 | 42 | 0.070 |
Why?
|
Pulmonary Alveoli | 1 | 2010 | 653 | 0.070 |
Why?
|
Aged | 15 | 2021 | 168995 | 0.070 |
Why?
|
Proteins | 1 | 2002 | 6030 | 0.070 |
Why?
|
DNA Mutational Analysis | 2 | 2013 | 4109 | 0.070 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 616 | 0.070 |
Why?
|
Down-Regulation | 2 | 2012 | 2918 | 0.070 |
Why?
|
Survival Rate | 3 | 2017 | 12806 | 0.070 |
Why?
|
Cyclin D | 1 | 2006 | 72 | 0.070 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2009 | 277 | 0.070 |
Why?
|
Fluorocarbons | 1 | 2012 | 483 | 0.070 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2282 | 0.070 |
Why?
|
Male | 20 | 2020 | 359413 | 0.070 |
Why?
|
Translocation, Genetic | 1 | 2012 | 1388 | 0.070 |
Why?
|
Pneumothorax | 1 | 2009 | 377 | 0.070 |
Why?
|
Tumor Suppressor Proteins | 1 | 2016 | 2804 | 0.070 |
Why?
|
Middle Aged | 15 | 2019 | 220175 | 0.060 |
Why?
|
Leukemia, Erythroblastic, Acute | 1 | 2006 | 176 | 0.060 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2009 | 666 | 0.060 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2010 | 612 | 0.060 |
Why?
|
Oxygen | 1 | 2017 | 4189 | 0.060 |
Why?
|
Caspases | 2 | 1999 | 878 | 0.060 |
Why?
|
HEK293 Cells | 1 | 2014 | 4264 | 0.060 |
Why?
|
Aged, 80 and over | 8 | 2018 | 58947 | 0.060 |
Why?
|
DNA, Neoplasm | 2 | 2013 | 1745 | 0.060 |
Why?
|
Genetic Variation | 1 | 2020 | 6540 | 0.060 |
Why?
|
Models, Structural | 1 | 2005 | 341 | 0.060 |
Why?
|
Transfection | 3 | 2009 | 5782 | 0.060 |
Why?
|
Milk Proteins | 1 | 2005 | 163 | 0.060 |
Why?
|
Cycloheximide | 2 | 2002 | 343 | 0.060 |
Why?
|
Caspase 3 | 3 | 2002 | 730 | 0.060 |
Why?
|
STAT5 Transcription Factor | 1 | 2005 | 264 | 0.060 |
Why?
|
Leukemia, Myeloid | 1 | 2007 | 696 | 0.060 |
Why?
|
Interleukin-3 | 1 | 2005 | 429 | 0.060 |
Why?
|
Hypoxanthine Phosphoribosyltransferase | 1 | 2024 | 69 | 0.060 |
Why?
|
Purine Nucleotides | 1 | 2024 | 27 | 0.060 |
Why?
|
Genotype | 3 | 2015 | 12959 | 0.060 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2006 | 431 | 0.060 |
Why?
|
Amino Acid Sequence | 4 | 2021 | 13456 | 0.060 |
Why?
|
Flavonoids | 1 | 2006 | 444 | 0.060 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2006 | 656 | 0.050 |
Why?
|
Alopecia | 1 | 2007 | 415 | 0.050 |
Why?
|
Tyrphostins | 1 | 2022 | 63 | 0.050 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2006 | 270 | 0.050 |
Why?
|
X-Linked Inhibitor of Apoptosis Protein | 1 | 2002 | 60 | 0.050 |
Why?
|
Thymidine Phosphorylase | 1 | 2002 | 14 | 0.050 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2022 | 149 | 0.050 |
Why?
|
RNA, Neoplasm | 1 | 2005 | 749 | 0.050 |
Why?
|
Retrospective Studies | 9 | 2019 | 80301 | 0.050 |
Why?
|
Proto-Oncogenes | 1 | 2022 | 320 | 0.050 |
Why?
|
Doxorubicin | 2 | 2019 | 2207 | 0.050 |
Why?
|
Mice, Knockout | 2 | 2015 | 14396 | 0.050 |
Why?
|
Poly Adenosine Diphosphate Ribose | 1 | 2021 | 50 | 0.050 |
Why?
|
Polyenes | 1 | 2021 | 68 | 0.050 |
Why?
|
Microscopy | 1 | 2006 | 881 | 0.050 |
Why?
|
Adipocytes | 1 | 2008 | 1179 | 0.050 |
Why?
|
Prognosis | 4 | 2016 | 29636 | 0.050 |
Why?
|
Erythroid Precursor Cells | 1 | 2021 | 211 | 0.050 |
Why?
|
Epoxy Compounds | 1 | 2021 | 136 | 0.050 |
Why?
|
Drug Interactions | 1 | 2005 | 1426 | 0.050 |
Why?
|
Glucocorticoids | 1 | 2010 | 2143 | 0.050 |
Why?
|
Follow-Up Studies | 4 | 2016 | 39254 | 0.040 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2021 | 363 | 0.040 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2021 | 430 | 0.040 |
Why?
|
Cell Transdifferentiation | 1 | 2021 | 185 | 0.040 |
Why?
|
Ethylnitrosourea | 1 | 2019 | 51 | 0.040 |
Why?
|
Disease-Free Survival | 3 | 2017 | 6830 | 0.040 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2021 | 428 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2016 | 20048 | 0.040 |
Why?
|
Point Mutation | 1 | 2005 | 1594 | 0.040 |
Why?
|
Oxidative Phosphorylation | 1 | 2021 | 495 | 0.040 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2022 | 688 | 0.040 |
Why?
|
Piperazines | 1 | 2010 | 2520 | 0.040 |
Why?
|
Reoperation | 1 | 2009 | 4292 | 0.040 |
Why?
|
Alkylating Agents | 1 | 2019 | 133 | 0.040 |
Why?
|
Carcinoma | 1 | 2010 | 2334 | 0.040 |
Why?
|
Precursor Cells, B-Lymphoid | 1 | 2019 | 98 | 0.040 |
Why?
|
Oncogene Proteins | 1 | 2023 | 721 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 3 | 2017 | 20484 | 0.040 |
Why?
|
Republic of Korea | 1 | 2020 | 567 | 0.040 |
Why?
|
Epigenesis, Genetic | 1 | 2012 | 3758 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2006 | 3774 | 0.040 |
Why?
|
Mucin-1 | 1 | 2023 | 539 | 0.040 |
Why?
|
Forensic Pathology | 1 | 2017 | 23 | 0.040 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 1998 | 189 | 0.040 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2017 | 2500 | 0.040 |
Why?
|
Endothelial Cells | 1 | 2010 | 3537 | 0.040 |
Why?
|
Cell Aggregation | 1 | 2017 | 239 | 0.040 |
Why?
|
Amino Acids | 1 | 2023 | 1715 | 0.040 |
Why?
|
Sequence Analysis, RNA | 1 | 2005 | 2003 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 3333 | 0.030 |
Why?
|
Succinate Dehydrogenase | 1 | 2017 | 145 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2021 | 1837 | 0.030 |
Why?
|
Nitriles | 1 | 2021 | 955 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2021 | 1173 | 0.030 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2017 | 295 | 0.030 |
Why?
|
Molecular Dynamics Simulation | 1 | 2019 | 434 | 0.030 |
Why?
|
Mice, SCID | 1 | 2021 | 2627 | 0.030 |
Why?
|
Image Enhancement | 1 | 2006 | 2877 | 0.030 |
Why?
|
Treatment Outcome | 7 | 2019 | 64947 | 0.030 |
Why?
|
RNA, Messenger | 2 | 2021 | 12762 | 0.030 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2017 | 238 | 0.030 |
Why?
|
Ligands | 1 | 2022 | 3277 | 0.030 |
Why?
|
Pyrroles | 1 | 2021 | 1137 | 0.030 |
Why?
|
Cysteine Endopeptidases | 1 | 1998 | 548 | 0.030 |
Why?
|
Mutagenesis | 1 | 2019 | 1234 | 0.030 |
Why?
|
Antibodies, Monoclonal | 3 | 2009 | 9196 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 3 | 2012 | 6545 | 0.030 |
Why?
|
Protein Conformation | 2 | 2013 | 3969 | 0.030 |
Why?
|
Leukemia | 1 | 2022 | 1522 | 0.030 |
Why?
|
Gene Expression | 2 | 2020 | 7592 | 0.030 |
Why?
|
Conserved Sequence | 1 | 2017 | 1168 | 0.030 |
Why?
|
Molecular Sequence Data | 3 | 2013 | 17628 | 0.030 |
Why?
|
Structural Homology, Protein | 1 | 2013 | 86 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 2020 | 1767 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2011 | 11902 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 2005 | 4717 | 0.030 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2006 | 3335 | 0.030 |
Why?
|
Hematopoietic Stem Cells | 1 | 2006 | 3390 | 0.030 |
Why?
|
Indoles | 1 | 2021 | 1830 | 0.030 |
Why?
|
Cell Count | 1 | 2017 | 1838 | 0.030 |
Why?
|
HeLa Cells | 1 | 2019 | 3105 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2020 | 21065 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 1 | 2006 | 4044 | 0.030 |
Why?
|
Biopsy | 1 | 2005 | 6775 | 0.030 |
Why?
|
Models, Molecular | 2 | 2013 | 5429 | 0.030 |
Why?
|
Protein Binding | 2 | 2017 | 9336 | 0.030 |
Why?
|
Oligopeptides | 1 | 1998 | 1188 | 0.030 |
Why?
|
Mice, Inbred BALB C | 1 | 2021 | 6226 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2009 | 10340 | 0.020 |
Why?
|
Activin Receptors, Type II | 1 | 2012 | 123 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2020 | 1892 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2020 | 2008 | 0.020 |
Why?
|
CpG Islands | 1 | 2016 | 1221 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2015 | 1792 | 0.020 |
Why?
|
Esophageal Neoplasms | 1 | 2002 | 1651 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2014 | 877 | 0.020 |
Why?
|
Genomic Instability | 1 | 2015 | 704 | 0.020 |
Why?
|
Enzyme Activation | 3 | 2006 | 3604 | 0.020 |
Why?
|
Surface Plasmon Resonance | 1 | 2012 | 265 | 0.020 |
Why?
|
Phosphodiesterase I | 1 | 2010 | 7 | 0.020 |
Why?
|
Technology Transfer | 1 | 2011 | 42 | 0.020 |
Why?
|
Biotinylation | 1 | 2011 | 184 | 0.020 |
Why?
|
Disease Progression | 1 | 2008 | 13505 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 1999 | 2138 | 0.020 |
Why?
|
Prospective Studies | 4 | 2020 | 54263 | 0.020 |
Why?
|
Lysophospholipase | 1 | 2010 | 65 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2020 | 2441 | 0.020 |
Why?
|
Adult | 8 | 2018 | 219847 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2013 | 747 | 0.020 |
Why?
|
Receptors, Lysophosphatidic Acid | 1 | 2010 | 77 | 0.020 |
Why?
|
Genomics | 2 | 2018 | 5790 | 0.020 |
Why?
|
Oncogenes | 1 | 2016 | 1221 | 0.020 |
Why?
|
Pyrophosphatases | 1 | 2010 | 139 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2020 | 2895 | 0.020 |
Why?
|
Bacteriophage T7 | 1 | 2011 | 174 | 0.020 |
Why?
|
Gene Silencing | 1 | 2016 | 1511 | 0.020 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2010 | 199 | 0.020 |
Why?
|
Stereoisomerism | 1 | 2010 | 618 | 0.020 |
Why?
|
Cricetulus | 1 | 2011 | 815 | 0.020 |
Why?
|
Isoenzymes | 1 | 2014 | 1690 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2013 | 1979 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2016 | 2214 | 0.020 |
Why?
|
CHO Cells | 1 | 2011 | 1389 | 0.020 |
Why?
|
Caspase 9 | 2 | 1999 | 186 | 0.020 |
Why?
|
Caspase 8 | 2 | 1999 | 188 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2005 | 9590 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2007 | 15766 | 0.020 |
Why?
|
3T3-L1 Cells | 1 | 2008 | 209 | 0.020 |
Why?
|
Genes, abl | 1 | 2007 | 69 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2009 | 670 | 0.020 |
Why?
|
Cricetinae | 1 | 2011 | 2427 | 0.020 |
Why?
|
Gene Dosage | 1 | 2012 | 1218 | 0.020 |
Why?
|
Receptors, Lymphocyte Homing | 1 | 2007 | 142 | 0.020 |
Why?
|
Feedback, Physiological | 1 | 2010 | 476 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2012 | 1617 | 0.020 |
Why?
|
Melanoma, Experimental | 1 | 2010 | 562 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 2012 | 6543 | 0.020 |
Why?
|
Multienzyme Complexes | 1 | 2010 | 666 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2010 | 642 | 0.020 |
Why?
|
Myeloid Progenitor Cells | 1 | 2007 | 114 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2011 | 2178 | 0.020 |
Why?
|
Eukaryotic Initiation Factor-4E | 1 | 2007 | 112 | 0.020 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2011 | 859 | 0.020 |
Why?
|
Genes, ras | 1 | 2009 | 654 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2010 | 1549 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2005 | 9274 | 0.020 |
Why?
|
Inhibitor of Differentiation Protein 1 | 1 | 2006 | 47 | 0.020 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 2007 | 180 | 0.020 |
Why?
|
Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2006 | 88 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2017 | 3601 | 0.020 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2007 | 263 | 0.020 |
Why?
|
Algorithms | 1 | 2006 | 13967 | 0.020 |
Why?
|
Retroviridae | 1 | 2008 | 850 | 0.020 |
Why?
|
GATA1 Transcription Factor | 1 | 2006 | 296 | 0.020 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2007 | 629 | 0.010 |
Why?
|
Serine | 1 | 2008 | 831 | 0.010 |
Why?
|
Cohort Studies | 1 | 2007 | 41317 | 0.010 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2007 | 556 | 0.010 |
Why?
|
Cell Cycle | 1 | 2012 | 2937 | 0.010 |
Why?
|
Biological Transport | 1 | 2008 | 2087 | 0.010 |
Why?
|
Plasmids | 1 | 2008 | 2277 | 0.010 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 3223 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 2006 | 2014 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2018 | 6457 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 4573 | 0.010 |
Why?
|
Macrophages | 1 | 2016 | 5745 | 0.010 |
Why?
|
Protein Kinases | 1 | 2008 | 1612 | 0.010 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2006 | 685 | 0.010 |
Why?
|
Quinolines | 1 | 2006 | 759 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2010 | 3443 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2010 | 22025 | 0.010 |
Why?
|
Computational Biology | 1 | 2012 | 3504 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2012 | 8551 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2007 | 2104 | 0.010 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2006 | 1137 | 0.010 |
Why?
|
Smoking | 1 | 2017 | 9070 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2007 | 4900 | 0.010 |
Why?
|
Affinity Labels | 1 | 1999 | 107 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2006 | 3800 | 0.010 |
Why?
|
Peptides | 1 | 2011 | 4358 | 0.010 |
Why?
|
Protein Synthesis Inhibitors | 1 | 1999 | 189 | 0.010 |
Why?
|
Medical Oncology | 1 | 2010 | 2321 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 2002 | 1705 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2007 | 3531 | 0.010 |
Why?
|
Caspase 6 | 1 | 1998 | 15 | 0.010 |
Why?
|
Caspase 7 | 1 | 1998 | 50 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2009 | 3483 | 0.010 |
Why?
|
Nuclear Matrix-Associated Proteins | 1 | 1998 | 38 | 0.010 |
Why?
|
Software | 1 | 2012 | 4420 | 0.010 |
Why?
|
Risk Assessment | 2 | 2011 | 24086 | 0.010 |
Why?
|
Superoxides | 1 | 1999 | 387 | 0.010 |
Why?
|
DNA Fragmentation | 1 | 1998 | 237 | 0.010 |
Why?
|
Antigens, Nuclear | 1 | 1998 | 184 | 0.010 |
Why?
|
RNA Interference | 1 | 2006 | 2846 | 0.010 |
Why?
|
Recurrence | 1 | 2009 | 8487 | 0.010 |
Why?
|
Homeostasis | 1 | 2008 | 3305 | 0.010 |
Why?
|
Jurkat Cells | 1 | 1998 | 736 | 0.010 |
Why?
|
Glucose | 1 | 2008 | 4361 | 0.010 |
Why?
|
Brain | 1 | 2022 | 26912 | 0.010 |
Why?
|
Immunoblotting | 1 | 1999 | 1649 | 0.010 |
Why?
|
Sex Factors | 1 | 2009 | 10530 | 0.010 |
Why?
|
Stem Cells | 1 | 2007 | 3525 | 0.010 |
Why?
|
Genome, Human | 1 | 2007 | 4416 | 0.010 |
Why?
|
Autoantigens | 1 | 1998 | 877 | 0.010 |
Why?
|
Phenotype | 1 | 2011 | 16543 | 0.010 |
Why?
|
Neoplasms | 1 | 2021 | 22066 | 0.010 |
Why?
|
Age Factors | 1 | 2009 | 18415 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2006 | 14656 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2011 | 17766 | 0.010 |
Why?
|
Survival Analysis | 1 | 2002 | 10185 | 0.010 |
Why?
|
Flow Cytometry | 1 | 1998 | 5873 | 0.000 |
Why?
|
Time Factors | 1 | 2009 | 40133 | 0.000 |
Why?
|
Cell Cycle Proteins | 1 | 1998 | 3448 | 0.000 |
Why?
|
Nuclear Proteins | 1 | 1998 | 5793 | 0.000 |
Why?
|
Young Adult | 1 | 2009 | 58673 | 0.000 |
Why?
|
Adolescent | 1 | 2009 | 87747 | 0.000 |
Why?
|